Based on these analysis, we found that ALKBH5 and IGF2BP2 could regulate the immune status of ovarian cancer microenvironment mainly through its mRNA expression levels, the mutation status of ALKBH5 and IGF2BP2 might not influence the immune status of ovarian cancer. The gene discussed is IGF2BP2; the disease is ovarian carcinoma.